A Tufts University review and meta-analysis of 21 randomized adult trials found non-nutritive sweeteners raised fasting insulin and HbA1c versus non-caloric controls, with a trend toward worse insulin sensitivity.
Water and placebo comparators helped isolate the sweeteners' direct physiological effects rather than the calories they replaced, strengthening the signal of possible metabolic harm.
One mechanism under review is the gut microbiome: in a trial with microbiome profiling and human-to-mouse transfers, some low-calorie sweeteners altered gut microbial composition and function.
Large observational studies the team reviewed also linked sweetener use to higher cardiometabolic disease risk, though the authors said reverse causation and differences among sweeteners limit firm conclusions.
The researchers urged caution as use expands, and said missing US label disclosure of sweetener amounts makes long-term population studies and clearer risk estimates harder.
With scientists clashing over sweeteners, are they a safe sugar substitute or a hidden metabolic risk?
As risks of fake sugars emerge, why aren't companies required to reveal how much is in your food?
Artificial Sweeteners Under Scrutiny: Metabolic Health Risks, Policy Changes, and Consumer Guidance
Overview
Artificial sweeteners, or non-nutritive sweeteners (NNS), are being consumed more rapidly than science can keep up with their long-term health effects. Once thought to be safe alternatives to sugar, new research is challenging this assumption and calling for caution. Recent findings show a concerning link between calorie-free sweeteners and the body's ability to control blood sugar, suggesting possible short-term harm. While NNS may be better than large amounts of added sugar, experts now recommend avoiding them when possible until more comprehensive data is available, highlighting the need for a careful and informed approach.